#1
#1 out of 1
business1d ago
AstraZeneca makes surprise U-turn with £300m pharma investment in UK
- AstraZeneca pledged £300 million for UK sites, reversing a pause on major investments.
- Funds will unfreeze £200m in Cambridge and add £100m to Macclesfield’s site expansion.
- Keir Starmer announced the plan in the House of Commons, calling it a vote of confidence in UK science.
- Cambridge office will be completed near AstraZeneca’s headquarters and named after Rosalind Franklin.
- AstraZeneca’s new Macclesfield lab aims to use digital tools to speed drug development.
- The UK-US pricing deal helped enable the investment and aims to safeguard jobs.
- AstraZeneca employs about 10,000 people in the UK, with significant numbers in Cambridge and Macclesfield.
- Industry confidence in UK life sciences grows alongside the new investment plan.
- Other firms, including Boehringer Ingelheim and GSK, are expanding UK presence amid the momentum.
- Analysts see AstraZeneca's move as strategically reinforcing the UK life sciences sector.
Vote 0